1. Home
  2. TBPH vs THFF Comparison

TBPH vs THFF Comparison

Compare TBPH & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • THFF
  • Stock Information
  • Founded
  • TBPH 2013
  • THFF 1984
  • Country
  • TBPH United States
  • THFF United States
  • Employees
  • TBPH N/A
  • THFF N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • THFF Major Banks
  • Sector
  • TBPH Health Care
  • THFF Finance
  • Exchange
  • TBPH Nasdaq
  • THFF Nasdaq
  • Market Cap
  • TBPH 536.5M
  • THFF 625.8M
  • IPO Year
  • TBPH N/A
  • THFF N/A
  • Fundamental
  • Price
  • TBPH $10.90
  • THFF $52.44
  • Analyst Decision
  • TBPH Strong Buy
  • THFF Buy
  • Analyst Count
  • TBPH 5
  • THFF 3
  • Target Price
  • TBPH $16.60
  • THFF $59.50
  • AVG Volume (30 Days)
  • TBPH 158.6K
  • THFF 54.5K
  • Earning Date
  • TBPH 08-12-2025
  • THFF 07-22-2025
  • Dividend Yield
  • TBPH N/A
  • THFF 3.89%
  • EPS Growth
  • TBPH N/A
  • THFF 21.43
  • EPS
  • TBPH N/A
  • THFF 5.24
  • Revenue
  • TBPH $65,266,000.00
  • THFF $230,446,000.00
  • Revenue This Year
  • TBPH $51.74
  • THFF $30.73
  • Revenue Next Year
  • TBPH N/A
  • THFF $2.82
  • P/E Ratio
  • TBPH N/A
  • THFF $10.01
  • Revenue Growth
  • TBPH 6.11
  • THFF 19.59
  • 52 Week Low
  • TBPH $7.44
  • THFF $38.87
  • 52 Week High
  • TBPH $11.88
  • THFF $57.91
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 45.21
  • THFF 37.75
  • Support Level
  • TBPH $10.90
  • THFF $54.73
  • Resistance Level
  • TBPH $11.26
  • THFF $56.18
  • Average True Range (ATR)
  • TBPH 0.24
  • THFF 1.38
  • MACD
  • TBPH -0.08
  • THFF -0.54
  • Stochastic Oscillator
  • TBPH 2.00
  • THFF 9.28

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.

Share on Social Networks: